Prescription Drug Monitoring Program: Wisconsin State Profile (2021)

• NCJ Number: 303774
• Date Published: 2021
• Length: 12 pages
• Grant Number(s): 2017–AR–BX–K003
• Agencies: BJA-Sponsored
• Publication Type: Report (Grant Sponsored)

Annotation

The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) presents 2020 data and 2021 features of Wisconsin’s Prescription Drug Monitoring Program (PDMP)

Abstract

• The acronym of Wisconsin’s PDMP is WI PDMP. It is administered by the Wisconsin Controlled Substances Board. The email address is provided, along with the URLs of the main PDMP website and related websites for registration, queries, statistics, opioid dashboard, and statutes/regulations. Contact information is provided for the PDMP Program and Policy Analyst. In 2020, the state population was 5,897,473, and there were 35,266 DEA-registered prescribers and 1,175 DEA-registered dispensers. Ten entities transmit prescription drug data to the PDMP. Substances monitored are drugs listed on Schedules II-V, and data are maintained on naloxone/narcan dispensations. Alternate data sources listed are lost/stolen prescription drug reports, fatal and non-fatal drug overdoses, and patient lock-in information. A total of 23 reports available from the PDMP are listed, along with 27 statistical capabilities of the PDMP. Forty-six Authorized PDMP users are listed, representing the fields of correctional supervision. prosecution, law enforcement, prescribers, dispensers, healthcare, researchers, and state health departments. A total of 41 engaged PDMP users are listed. Funding sources for the PDMP are a BJA grant, licensing fees, and a CDC grant. The 2021 PDMP budget amount is not reported. There are four staff members; two perform operational tasks and two perform analytical tasks. Thirteen technologies used by the PDMP are listed. Patient-matching capabilities are reported, as well as the integrations available. State data-sharing partners are listed, along with descriptions and dates of significant events in the PDMP’s development. Prescribers are required to use the PDMP. Other information provided pertains to PDMP queries, unsolicited reports/push notifications, and policies on veterinarians use of the PDMP.